Stocktoria

MIMEDX GROUP, INC. MDXG

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-08-20

MIMEDX GROUP, INC. statistics & valuation

Market cap$585.4M
P / E12.0×
P / S1.4×
P / B2.3×
Net margin11.6%
Return on equity18.9%
Net cash$148.1M
Net debt / EBITDA-1.9×
Enterprise value USD$437.2M
EV / EBITDA5.6×
Earnings yield EBIT/EV14.6%
Return on capital22.9%
Graham number -17.9%$3.51

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($3.51); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
0.20% 20.20% -8.30% -8.50% -19.90% -4.20% -11.30% 18.10% 12.20% 11.60% 2016201720182019202020212022202320242025
Gross margin (%)
86.00% 89.00% 89.90% 85.60% 84.20% 83.60% 82.00% 83.00% 82.80% 82.60% 2016201720182019202020212022202320242025
Operating margin (%)
0.40% 14.40% -1.10% -7.10% -18.30% -2.90% -5.50% 11.50% 16.90% 15.30% 2016201720182019202020212022202320242025
Return on equity (%)
0.80% 87.70% -60.40% -74.40% -12542.70% 40.80% 22.00% 18.90% 2016201720182019202020212022202320242025
Shares outstanding
112.6M 116.1M 109.1M 110.8M 110.9M 111.9M 113.7M 146.2M 149.0M 149.7M 2016201720182019202020212022202320242025
Net debt ($)
-$45.1M $4.1M -$45.8M -$37.1M -$15.9M -$32.0M -$85.4M -$148.1M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
0.30% 53.40% -24.40% -15.30% -24.40% -5.50% -17.60% 24.40% 16.10% 14.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-5.40% -7.20% 10.20% 2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 2.13× 609.76× 0.35× 0.10× 0.07× 2016201720182019202020212022202320242025
EPS ($)
$0.00 $0.56 -$0.28 -$0.24 -$0.77 -$0.15 -$0.33 $0.37 $0.28 $0.32 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

MIMEDX GROUP, INC. trades at about 13.4× earnings — below its 10-year norm (10-year range 16×–163×, median 31.1×).

13.4× 163×

Shaded band = 10-year range (16×–163×); dot = today's 13.4×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin82.6%82.8%83.0%82.0%83.6%84.2%85.6%89.9%89.0%86.0%
Operating margin15.3%16.9%11.5%-5.5%-2.9%-18.3%-7.1%-1.1%14.4%0.4%
Net margin11.6%12.2%18.1%-11.3%-4.2%-19.9%-8.5%-8.3%20.2%0.2%
FCF margin——10.2%-7.2%-5.4%—————
Return on assets14.2%16.1%24.4%-17.6%-5.5%-24.4%-15.3%-24.4%53.4%0.3%
Return on equity18.9%22.0%40.8%167.9%-12542.7%32856.0%-74.4%-60.4%87.7%0.8%
Debt / equity0.07×0.10×0.35×-2.78×609.76×-333.33×2.13×0.00×——
Current ratio4.324.213.573.083.512.711.831.031.060.98

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.